Rockwell Medical (NASDAQ:RMTI) Coverage Initiated at began coverage on shares of Rockwell Medical (NASDAQ:RMTIGet Rating) in a research note published on Monday morning. The brokerage issued a hold rating on the stock.

Separately, HC Wainwright upped their price target on Rockwell Medical to $8.00 and gave the company a buy rating in a research note on Tuesday, August 30th.

Rockwell Medical Trading Up 3.7 %

Rockwell Medical stock opened at $1.12 on Monday. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.19 and a quick ratio of 1.93. Rockwell Medical has a 52 week low of $0.84 and a 52 week high of $7.15. The business’s fifty day moving average is $1.16 and its two-hundred day moving average is $1.45.

Institutional Investors Weigh In On Rockwell Medical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in RMTI. Jane Street Group LLC bought a new stake in Rockwell Medical in the third quarter valued at about $28,000. Renaissance Technologies LLC increased its holdings in Rockwell Medical by 24.7% in the first quarter. Renaissance Technologies LLC now owns 281,234 shares of the company’s stock valued at $133,000 after purchasing an additional 55,700 shares during the last quarter. Finally, Armistice Capital LLC increased its holdings in Rockwell Medical by 364.4% in the third quarter. Armistice Capital LLC now owns 959,000 shares of the company’s stock valued at $1,266,000 after purchasing an additional 752,490 shares during the last quarter.

Rockwell Medical Company Profile

(Get Rating)

Rockwell Medical, Inc, together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores.

See Also

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with's FREE daily email newsletter.